• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[有组织人群中动脉高血压的二级预防:实施方法、疗效及前景]

[Secondary prevention of arterial hypertension in an organized population: methods of implementation, efficacy, prospects].

作者信息

Merzon A K, Kolomiets V V, Reznichenko L I

出版信息

Kardiologiia. 1987 Jan;27(1):69-74.

PMID:3560632
Abstract

Five-year follow-up of an organized population of males between 35 and 54 years of age and medication of patients with arterial hypertension (AH) demonstrated possibilities of considerably reducing the incidence of cerebral insult (by 42.9%) and myocardial infarction (by 15.5%) and the respective mortality rates (by 56.1% and 23.8%), invalidism associated with cardiovascular diseases (by 36%), temporary disability because of AH (by 38.2%). The efficiency of treatment for AH increases considerably where medication is given on a regular basis. Possible approaches to improving the efficiency of secondary AH prevention within an organized population are discussed, as are possibilities of introducing preventive measures in routine work of the factory therapeutic service.

摘要

对35至54岁男性有组织群体的五年随访以及对动脉高血压(AH)患者的药物治疗表明,有很大可能大幅降低脑卒发病率(降低42.9%)和心肌梗死发病率(降低15.5%)以及相应的死亡率(分别降低56.1%和23.8%)、与心血管疾病相关的残疾率(降低36%)、因AH导致的临时残疾率(降低38.2%)。在定期给药的情况下,AH治疗的效率会大幅提高。文中讨论了在有组织群体中提高继发性AH预防效率的可能方法,以及在工厂治疗服务日常工作中引入预防措施的可能性。

相似文献

1
[Secondary prevention of arterial hypertension in an organized population: methods of implementation, efficacy, prospects].[有组织人群中动脉高血压的二级预防:实施方法、疗效及前景]
Kardiologiia. 1987 Jan;27(1):69-74.
2
[Prospective epidemiologic study of arterial hypertension in an organized male population].
Kardiologiia. 1987 Jan;27(1):74-7.
3
Medical efficacy of a cooperative prevention programme of arterial hypertension.
Cor Vasa. 1988;30(2):97-104.
4
[Results of the secondary prevention of arterial hypertension. Study Group of the All-Union Collective Program for the Prevention of Arterial Hypertension (AUCPPAH)].[动脉高血压二级预防的结果。全苏动脉高血压预防集体计划(AUCPPAH)研究组]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1986;9(1):56-62.
5
[Prevention of vascular diseases of the brain complicating hypertension in industrial enterprises].[预防工业企业中高血压并发的脑血管疾病]
Sov Med. 1987(5):52-4.
6
[TEMPORARY DISABILITY IN CARDIOVASCULAR DISEASES IN URAL HEAVY INDUSTRY FACTORIES].
Sov Zdravookhr. 1963 May;22:11-4.
7
[Results of the prevention of stroke in high risk groups].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(1):20-3.
8
[Late results in the management of hypertension].[高血压治疗的远期结果]
Ther Umsch. 1972 Jun;29(6):392-6.
9
[Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:59-63.
10
[Calculation of the size of the population group necessary for evaluation of the results of measures for the prevention of cardiovascular diseases (on the example of the Kaunas survey)].[评估心血管疾病预防措施效果所需人群组规模的计算(以考纳斯调查为例)]
Kardiologiia. 1977 Aug;17(8):10-6.